Pirfekast-200

Pirfekast-200

Composition – Pirefenidone – 200mg

Classification – Anti-fibrotic medicine

What is Pirfekast?

It is widely used to reduce scarring of the lung tissue. The lung tissues scar to form a hard fibrous mass, leading to difficulty in breathing.

Uses of Pirfekast

• • Idiopathic pulmonary fibrosis
• • Anti-fibrotic
• • Anti-inflammatory

Benefits

• • It delays disease progression
• • Preserve lung functions
• • Improves quality of life

Working of Pirfekast

• • It reduces growth factors involved in tissue fibrosis.
• • It reduces the rate of tissue scarring.
• • Reduces inflammation

Common side-effects of Pirfekast

• • Nausea
• • Vomiting
• • Photosensitivity
• • Headache
• • Respiratory infections
• • Weight loss

Side effects that can be serious

• • Jaundice
• • Unusual bleeding and bruising
• • Severe skin rash
• • Allergic reaction

Precautions while using Pirfekast

To be used cautiously in –

• • End-stage liver disease
• • Kidney disorders

Drug Interactions

• • Antidepressants
• • Heart medicines
• • Antibiotics

Contraindication

• • Any allergy to drug components.
• • Pregnancy or breastfeeding.
• • Not recommended for children below 18 years of age.

Warnings

• • To be used under medical supervision
• • Avoid alcohol consumption
• • Avoid smoking
• • Avoid grapefruits

Storage

• • Store at room temperature
• • Protect from light

Aprazer’s Leadership in Targeted Medicines for Rare Diseases

Aprazer Healthcare is the leading pharmaceutical company that manufactures targeted therapy drugs for rare conditions like pulmonary fibrosis, cardiovascular emergencies, and life-threatening infections.

With world-class infrastructure and continuous research and drug development, we are focused on manufacturing advanced drug molecules and a wide range of generic medicines for rare diseases and conditions.

We are a leading pharmaceutical exporter known for our unwavering commitment to quality. Our WHO-GMP-certified facilities ensure that every medicine we produce meets the highest global standards.